Krystal Biotech, Inc.

NASDAQ:KRYS

177.37 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Operating Activities:
Net Income 89.15910.932-139.975-69.57-32.167-19.088-10.889-7.92-1.15
Depreciation & Amortization 6.7145.0074.0552.7691.8510.7480.1410.0230.002
Deferred Income Tax 000000000
Stock Based Compensation 49.12739.93333.2315.3193.2721.2390.7920.2460.033
Change In Working Capital -14.457-37.8822.8112.0520.928-1.6790.5110.498-0.203
Accounts Receivables -62.706-42.040000000
Inventory -11.907-4.4750000000
Accounts Payables 1.011-0.101-1.2540.7120.783-0.1990.1120.1330.042
Other Working Capital 59.1458.7344.0651.340.145-1.480.3990.365-0.245
Other Non Cash Items -7.123-106.794-0.691.4920.0330.0670.9623.2630.007
Operating Cash Flow 123.42-88.804-100.569-47.938-26.083-18.713-9.445-3.89-1.311
Investing Activities:
Investments In Property Plant And Equipment -4.238-11.799-52.979-68.336-14.843-6.399-2.234-0.21-0.015
Acquisitions Net 000000000
Purchases Of Investments -457.74-508.776-318.781-190.462-3.205-9.07-8.08900
Sales Maturities Of Investments 298.539503.213257.67732.0286.86710.501000
Other Investing Activites 01000000000
Investing Cash Flow -163.43982.638-114.083-226.77-11.181-4.968-10.323-0.21-0.015
Financing Activities:
Debt Repayment 00000002.2991.843
Common Stock Issued 0203.49935.996355.645118.019107.52573.84742.4690.1
Common Stock Repurchased 000000000
Dividends Paid 000000000
Other Financing Activities 27.014-0.749-0.649-7.9600071.306
Financing Cash Flow 27.014202.7535.347347.685118.019107.52573.84751.7683.249
Other Information:
Effect Of Forex Changes On Cash -0.458-0.156-0.041000000
Net Change In Cash -13.463196.428-179.34672.97780.75583.84454.07947.6681.923
Cash At End Of Period 344.865358.328161.9341.246268.269187.514103.6749.5911.923